A detailed history of Fiduciary Trust CO transactions in Abbott Laboratories stock. As of the latest transaction made, Fiduciary Trust CO holds 301,855 shares of ABT stock, worth $34.5 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
301,855
Previous 305,580 1.22%
Holding current value
$34.5 Million
Previous $31.8 Million 8.38%
% of portfolio
0.49%
Previous 0.49%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $372,760 - $440,034
-3,725 Reduced 1.22%
301,855 $34.4 Million
Q2 2024

Aug 14, 2024

SELL
$100.73 - $112.44 $90,354 - $100,858
-897 Reduced 0.29%
305,580 $31.8 Million
Q1 2024

May 13, 2024

SELL
$109.52 - $120.96 $170,194 - $187,971
-1,554 Reduced 0.5%
306,477 $34.8 Million
Q4 2023

Feb 12, 2024

SELL
$90.19 - $110.4 $359,767 - $440,385
-3,989 Reduced 1.28%
308,031 $33.9 Million
Q3 2023

Nov 14, 2023

SELL
$95.53 - $114.62 $482,235 - $578,601
-5,048 Reduced 1.59%
312,020 $30.2 Million
Q2 2023

Aug 01, 2023

SELL
$100.78 - $112.29 $258,601 - $288,136
-2,566 Reduced 0.8%
317,068 $34.6 Million
Q1 2023

May 15, 2023

SELL
$96.86 - $114.01 $429,864 - $505,976
-4,438 Reduced 1.37%
319,634 $32.4 Million
Q4 2022

Feb 13, 2023

SELL
$95.06 - $111.52 $107,988 - $126,686
-1,136 Reduced 0.35%
324,072 $35.6 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $791,690 - $916,629
-8,182 Reduced 2.45%
325,208 $31.5 Million
Q2 2022

Aug 12, 2022

SELL
$102.07 - $123.37 $477,381 - $577,001
-4,677 Reduced 1.38%
333,390 $36.2 Million
Q1 2022

May 12, 2022

SELL
$114.02 - $139.04 $798,254 - $973,419
-7,001 Reduced 2.03%
338,067 $40 Million
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $107,327 - $131,416
-929 Reduced 0.27%
345,068 $48.6 Million
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $448,674 - $496,364
-3,846 Reduced 1.1%
345,997 $40.9 Million
Q2 2021

Aug 16, 2021

BUY
$105.79 - $124.53 $906,937 - $1.07 Million
8,573 Added 2.51%
349,843 $40.6 Million
Q1 2021

May 19, 2021

SELL
$108.84 - $128.23 $819,021 - $964,930
-7,525 Reduced 2.16%
341,270 $40.9 Million
Q4 2020

Jan 26, 2021

BUY
$105.0 - $114.42 $2 Million - $2.18 Million
19,032 Added 5.77%
348,795 $38.2 Million
Q3 2020

Nov 13, 2020

SELL
$91.64 - $111.29 $347,223 - $421,677
-3,789 Reduced 1.14%
329,763 $35.9 Million
Q2 2020

Aug 13, 2020

SELL
$76.57 - $98.0 $223,814 - $286,454
-2,923 Reduced 0.87%
333,552 $30.5 Million
Q1 2020

May 15, 2020

BUY
$62.82 - $91.86 $57,982 - $84,786
923 Added 0.28%
336,475 $26.6 Million
Q4 2019

Feb 04, 2020

SELL
$78.51 - $87.4 $1.78 Million - $1.99 Million
-22,714 Reduced 6.34%
335,552 $29.1 Million
Q3 2019

Nov 12, 2019

BUY
$81.84 - $88.74 $597,104 - $647,447
7,296 Added 2.08%
358,266 $30 Million
Q2 2019

Aug 14, 2019

SELL
$72.88 - $85.0 $131,985 - $153,935
-1,811 Reduced 0.51%
350,970 $29.5 Million
Q1 2019

May 07, 2019

SELL
$66.22 - $80.06 $835,100 - $1.01 Million
-12,611 Reduced 3.45%
352,781 $28.2 Million
Q4 2018

Jan 29, 2019

SELL
$65.56 - $74.27 $108,436 - $122,842
-1,654 Reduced 0.45%
365,392 $26.4 Million
Q3 2018

Nov 13, 2018

SELL
$60.81 - $73.36 $277,536 - $334,815
-4,564 Reduced 1.23%
367,046 $26.9 Million
Q2 2018

Aug 03, 2018

SELL
$57.57 - $63.54 $421,930 - $465,684
-7,329 Reduced 1.93%
371,610 $22.7 Million
Q1 2018

May 08, 2018

BUY
$56.27 - $63.62 $349,492 - $395,143
6,211 Added 1.67%
378,939 $22.7 Million
Q4 2017

Jan 29, 2018

SELL
$53.68 - $57.47 $438,565 - $469,529
-8,170 Reduced 2.14%
372,728 $21.3 Million
Q3 2017

Nov 02, 2017

BUY
$48.06 - $53.64 $18.3 Million - $20.4 Million
380,898
380,898 $20.3 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Fiduciary Trust CO Portfolio

Follow Fiduciary Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Trust CO with notifications on news.